Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,689 public trials 444 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Recruiting

A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

NCT07405151

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • UPMC Hillman Cancer Center ( Site 3904) Pittsburgh, Pennsylvania, United States
  • Liga Norte Riograndense Contra o Cancer ( Site 3301) Natal, Rio Grande do Norte, Brazil
  • Beijing Cancer Hospital ( Site 2500) Beijing, Beijing Municipality, China
  • Masarykuv onkologicky ustav ( Site 4000) Brno, Brno-mesto, Czechia
View all 32 locations
View Trial Details
Recruiting

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

NCT05952934

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
View Trial Details
Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT07217171

Conditions
Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more
Locations
  • City of Hope Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
  • The Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 679 locations
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +82 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 20 locations
View Trial Details
Recruiting

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

NCT07714538

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +35 more
Locations
  • Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom
  • Liverpool University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom
  • NHS Greater Glasgow and Clyde Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, United Kingdom
View Trial Details
Recruiting

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

NCT07026474

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Klinikum Chemnitz gGmbH, Klinik für Radioonkologie Chemnitz, Germany
  • Klinikum Darmstadt GmbH, Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Gemeinschaftspraxis Hämatologie-Onkologie Dresden Dresden, Germany
  • Helios Klinikum Erfurt, Klinik für Strahlentherapie Erfurt, Germany
View all 24 locations
View Trial Details

Related conditions